Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections are increasingly available ...

Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can ...

Nearly 20 states are moving to restrict assistance programs that help people afford HIV medications and treatment.

Citing rising costs and shortfalls in federal support, about 20 states are toughening eligibility requirements for patients ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.

Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to pre-exposure prophylaxis (PrEP), based on data presented at ...

As the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) wrapped up, leading HIV experts reflected on the ...

Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...

Eighteen states are limiting access to HIV medications through ADAP programs as federal funding has remained largely flat despite rising costs, with others considering similar cuts.

The consolidated evidence reveals that there is considerable cross-country price variation, particularly for second-line regimens where prices increase significantly with income level highlighting ...

National Week of Prayer for the Healing of AIDS brings faith communities together for prayer, education, and advocacy to ...